Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy–Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices | Zendy

Thomas Cole | Zendy; John H. Contois | Zendy; György Csákó | Zendy; Joseph P. McConnell | Zendy; Alan T. Remaley | Zendy; Sridevi Devaraj | Zendy; Daniel M Hoefner | Zendy; Tonya Mallory | Zendy; Amar A Sethi | Zendy; G. Russell Warnick | Zendy

Open Access

Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy–Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Author(s) -

Thomas Cole,

John H. Contois,

György Csákó,

Joseph P. McConnell,

Alan T. Remaley,

Sridevi Devaraj,

Daniel M Hoefner,

Tonya Mallory,

Amar A Sethi,

G. Russell Warnick

Publication year - 2013

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2012.196733

Subject(s) - apolipoprotein b , association (psychology) , lipoprotein particle , medicine , division (mathematics) , lipoprotein , psychology , very low density lipoprotein , cholesterol , mathematics , arithmetic , psychotherapist

The number of circulating LDL particles is a strong indicator of future cardiovascular disease (CVD) events, even superior to the concentration of LDL cholesterol. Atherogenic (primarily LDL) particle number is typically determined either directly by the serum concentration of apolipoprotein B (apo B) or indirectly by nuclear magnetic resonance (NMR) spectroscopy of serum to obtain NMR-derived LDL particle number (LDL-P).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research